Literature DB >> 11162343

What is the potential cost-effectiveness of enforcing a prohibition on the sale of tobacco to minors?

J R DiFranza1, R M Peck, T E Radecki, J A Savageau.   

Abstract

BACKGROUND: Enforcement programs to halt the sale of tobacco to youths have been implemented across the United States. The potential cost-effectiveness of enforcement was evaluated under a range of assumptions regarding cost and impact.
METHODS: An enforcement model was constructed incorporating quarterly inspections of all tobacco vendors. The cost of discounted years of life saved was calculated using reported values regarding cost and a range of assumptions regarding the impact on youth tobacco use.
RESULTS: Inspecting an estimated 543,000 tobacco outlets would cost up to $190 million annually. Costs range from $44 to $8,200 per year of life saved depending on the discount rate and assumptions regarding cost, and efficacy. To compete in cost-effectiveness with implementing smoking cessation guidelines, enforcement would have to produce a 5% reduction in adolescent smoking at a cost of no more than $250 per vendor.
CONCLUSION: At this level of cost and effectiveness an enforcement program could save 10 times as many lives as the same amount spent on mammography or screening for colorectal carcinoma. A one-cent per pack cigarette tax could fully fund enforcement. Enforcement of tobacco sales laws deserves further study as one component of a multifaceted approach to tobacco use prevention. Copyright 2001 American Health Foundation and Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11162343     DOI: 10.1006/pmed.2000.0795

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  11 in total

1.  Web sites selling cigarettes: how many are there in the USA and what are their sales practices?

Authors:  K M Ribisl; A E Kim; R S Williams
Journal:  Tob Control       Date:  2001-12       Impact factor: 7.552

2.  Application of consumer protection authority in preventing tobacco sales to minors.

Authors:  B S Krevor; A Lieberman; K Gerlach
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

3.  [Prevention of coronary heart disease: smoking].

Authors:  T Heitzer; T Meinertz
Journal:  Z Kardiol       Date:  2005

4.  The federal initiative to halt the sale of tobacco to children--the Synar Amendment, 1992-2000: lessons learned.

Authors:  J R DiFranza; G F Dussault
Journal:  Tob Control       Date:  2005-04       Impact factor: 7.552

Review 5.  Implementation and research priorities for FCTC Articles 13 and 16: tobacco advertising, promotion, and sponsorship and sales to and by minors.

Authors:  Rebekah H Nagler; Kasisomayajula Viswanath
Journal:  Nicotine Tob Res       Date:  2013-01-04       Impact factor: 4.244

6.  Cost-effectiveness of tobacco control policies and programmes targeting adolescents: a systematic review.

Authors:  Teresa Leão; Anton E Kunst; Julian Perelman
Journal:  Eur J Public Health       Date:  2018-02-01       Impact factor: 3.367

7.  Evaluating the Impact of the Synar Program: Tobacco Access and Use among Youth in Mississippi, the South, and the U.S.

Authors:  Jerri S Avery; John P Bartkowski; Xiaohe Xu; Janelle Kohler; Melissa Mason
Journal:  Healthcare (Basel)       Date:  2019-12-22

Review 8.  A review of economic evaluations of tobacco control programs.

Authors:  Jennifer W Kahende; Brett R Loomis; Bishwa Adhikari; Latisha Marshall
Journal:  Int J Environ Res Public Health       Date:  2008-12-28       Impact factor: 3.390

9.  Enforcement of underage sales laws as a predictor of daily smoking among adolescents: a national study.

Authors:  Joseph R DiFranza; Judith A Savageau; Kenneth E Fletcher
Journal:  BMC Public Health       Date:  2009-04-17       Impact factor: 3.295

10.  Comparing effects of tobacco use prevention modalities: need for complex system models.

Authors:  Steve Sussman; David Levy; Kristen Hassmiller Lich; Crystal W Cené; Mimi M Kim; Louise A Rohrbach; Frank J Chaloupka
Journal:  Tob Induc Dis       Date:  2013-01-22       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.